2 hrs ago
Biopharma industry at highest risk for employee turnover
A new survey reveals it might be easier for companies in the biopharma industry to poach employees from one another, especially among employees who view themselves as underpaid.
Strides Arcolab Makes Strategic Investment In Oncobiologics Inc., USA
Strides Arcolab and Oncobiologics, Inc., today announced that Strides has made a series of strategic investments in Oncobiologics, Inc., a privately held New Jersey biopharmaceutical firm developing a pipeline of biosimilars and next generation biotherapeutics.
Merck KGaA Appoints New Global Head Of R&D For Biopharma Division
Merck KGaA's biopharmaceutical division today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.
Merck & Co. PT Raised to $60.00
Leerink Swann's target price suggests a potential upside of 3.15% from the company's current price.
Merck & Co., Inc.'s Pediatric Anti-Vomiting Drug Effective In Phase 3 Trial
Merck Announces Data from Investigational Phase 3 Study on EMENDA for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Children Undergoing Emetogenic Chemotherapy Merck Planning Regulatory Submissions in the U.S. for EMENDA in Pediatric Setting Including New Suspension Formulation in Second Half of 2014 WHITEHOUSE STATION, N.J.-- ... (more)
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before...
The field is predicated on the concept that the body's immune system can be augmented or taught to modulate cancer without the use of toxic chemotherapy agents and radiation, the standard of care today worldwide.
Wall Street gains after ruling on broadcasters
Shares of Bristol-Myers Squibb shot up 3 percent to $49.73. The rally came a day after the drugmaker said a late-stage trial testing its immunotherapy nivolumab in advanced melanoma patients was halted early after it was determined that the drug was likely to prolong survival.